[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
for
Metastatic Lobular Breast Carcinoma
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18 - 70+
Code: NCT07020806
Phase1, Recruiting
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 25 - 70+
Code: NCT03408353
Recruiting
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
for
Breast Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07047872
Recruiting
Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
for
BRCA1 Mutation, BRCA2 Mutation
Location: Durham NC, Chapel Hill NC
Sponsor: Duke University
Sex: Female
Age: 19 - 50
Code: NCT06972719
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
Interested in new breast cancer trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)